ATRC
AtriCure Inc
53.70$
-4.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +164.8% | -642.8% | – | +171.1% | -70.8% | -288.9% | – | +23.6% | -25.0% | -120.0% | – | – | |
| – | +1.7% | +6.5% | +1.7% | +8.9% | -2.1% | +5.3% | +1.7% | 0.0% | -1.2% | +3.3% | +0.6% | – | |
| – | +7.5% | -0.5% | +12.2% | -0.3% | +0.2% | -7.3% | +18.1% | +9.3% | -9.4% | +0.1% | +9.2% | – | |
| – | – | – | – | +19,350.8% | -160.2% | – | – | +39.9% | -98.5% | -15,766.4% | – | – | |
| – | -23.3% | -0.4% | -14.1% | +51.3% | +307.2% | -85.2% | +251.3% | -66.0% | +30.4% | +13.4% | -2.2% | – | |
| – | -123.5% | – | +220.3% | -85.8% | -434.5% | -88.6% | +355.8% | -66.0% | -0.1% | +48.0% | -2.2% | – | |
| – | +189.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.7% | +7,682.1% | -97.6% | -60.4% | +204.8% | +5,197.9% | -96.0% | -12.1% | -36.1% | +4,918.4% | -97.3% | – | |
| – | – | – | – | – | +4.5% | +2.1% | +1.7% | +3.1% | +6.6% | +272.0% | -72.0% | – | |
| – | +1,687.1% | -396.8% | – | -111.7% | – | -694.1% | – | +75.0% | -64.9% | -731.8% | – | – | |
| – | -72.2% | -621.1% | – | -40.8% | -131.3% | – | – | +67.9% | -34.9% | -208.7% | – | – | |
| – | – | -2,081.5% | – | +228.2% | -154.0% | – | – | +72.8% | -2.8% | -133.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.